First-line chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma with or without cetuximab: a single institution experience

Single Institution ◽

First Line ◽

The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1933-8 ◽

2012 ◽

Vol 70 (4) ◽

pp. 539-546 ◽

Cited By ~ 2

Author(s):

Han Sang Kim ◽

Hye Ryun Kim ◽

Gun Min Kim ◽

Hyo Song Kim ◽

Yoon Woo Koh ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

First Line ◽

Prognostic role of inflammatory index in head and neck squamous-cell carcinoma patients in first line chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e18054 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e18054-e18054

Author(s):

Valentina Fausti ◽

Federica Recine ◽

Flavia Foca ◽

Sebastiano Calpona ◽

Davide Bruschi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Role ◽

First Line ◽

Inflammatory Index ◽

First-line chemotherapy for head and neck squamous cell carcinoma. Optimal strategy

Head and neck tumors (HNT) ◽

10.17650/2222-1468-2018-8-4-14-20 ◽

2019 ◽

Vol 8 (4) ◽

pp. 14-20

Author(s):

L. V. Bolotina ◽

A. L. Kornietskaya ◽

A. D. Kaprin ◽

Е. Yu. Karpenko

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Optimal Strategy ◽

First Line ◽

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma

Case Medical Research ◽

10.31525/cmr-14e3317 ◽

2019 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3700967 ◽

2020 ◽

Author(s):

Joël Guigay ◽

Anne Aupérin ◽

Jerome Fayette ◽

Esma Saada-Bouzid ◽

Cédrik Lafond ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Line Treatment ◽

First Line ◽

First Line Treatment

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Annals of Oncology ◽

10.1093/annonc/mdy424.045 ◽

2018 ◽

Vol 29 ◽

pp. viii729 ◽

Cited By ~ 59

Author(s):

B. Burtness ◽

K.J. Harrington ◽

R. Greil ◽

D. Soulières ◽

M. Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase Iii ◽

First Line ◽

Phase Iii Study

Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?

European Journal of Cancer ◽

10.1016/s0959-8049(17)30453-7 ◽

2017 ◽

Vol 72 ◽

pp. S113 ◽

Cited By ~ 2

Author(s):

O. Regnier-Gavier ◽

P. Coliat ◽

H. Carinato ◽

M. Burgy ◽

D. Exinger ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Second Line ◽

Second Line Chemotherapy ◽

Line Chemotherapy ◽

Platinum Doublet

PD-1/PD-L1 blockade as first line systematic therapy in locally advanced cutaneous head and neck squamous cell carcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.11.145 ◽

2020 ◽

Vol 106 (5) ◽

pp. 1183

Author(s):

E. Ho ◽

K.S. Hu ◽

C.Z. Liu ◽

M. DeLacure ◽

M. Persky ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

First Line

101 INDUCTION CHEMOTHERAPY FOLLOWED BY LOCOREGIONAL TREATMENT IN T4 OR N3 HEAD AND NECK SQUAMOUS CELL CARCINOMA: A SINGLE INSTITUTION EXPERIENCE

Radiotherapy and Oncology ◽

10.1016/s0167-8140(12)72488-x ◽

2009 ◽

Vol 92 ◽

pp. S32

Author(s):

G. Delouya ◽

S. Clavel ◽

B. Fortin ◽

D. Soulières ◽

D. Charpentier ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Squamous Cell ◽

Single Institution ◽

Locoregional Treatment

The EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Treatment outcome in a single institution cohort

Acta Oncologica ◽

10.3109/0284186x.2014.964308 ◽

2014 ◽

Vol 54 (7) ◽

pp. 1071-1075 ◽

Cited By ~ 5

Author(s):

Charlotte Duch Lynggaard ◽

Marianne Hamilton Therkildsen ◽

Claus Andrup Kristensen ◽

Lena Specht

Keyword(s):

Squamous Cell Carcinoma ◽

Treatment Outcome ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Single Institution